High rate of prostate symptoms among ariaal men from Northern Kenya

Prostate

Volumn 62, Issue 1, 2005, Pages 83-90

  Campbell, Benjamin ^a  

^a USA   (United States)

Author keywords

Africa; Aging; Energetics; LUTS

Indexed keywords

TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ARTICLE; BODY FAT; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; FEVER; HUMAN; INDUSTRIALIZATION; KENYA; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SALIVA ANALYSIS; SALIVA LEVEL; SCORING SYSTEM; SKINFOLD THICKNESS; URINARY TRACT DISEASE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; KENYA; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREVALENCE; PROSTATIC HYPERPLASIA; TESTOSTERONE; TRANSIENTS AND MIGRANTS; URINATION DISORDERS;

EID: 10144226405     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20120     Document Type: Article

References (38)

1. Berry SJ, Coffey D, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-479.
2. Platz EA, Rimm EB, Kawachi I, Colditz GA, Stampfer MJ, Willett WC, et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol 1999;149:106-115.
3. Platz EA, Kawachi I, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998;158:2349-2356.
4. Koskimaki J, Hakama M, Huhtala H, Tammela TL. Association of dietary elements and lower urinary tract symptoms. Scand J Urol Nephrol 2000;34:46-50.
5. Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 2002;75:689-697.
6. Dahle SE, Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Hzing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002;168:599-604.
7. Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, et al. Obesity and benign prostate hyperplasia. Am J Epidemiol 1994;40:989-1002.
8. Platz EA, Rimm EB, Kawachi I, Colditz GA, Stampfer MJ, Willett WC, et al. Race, ethnicity and benign prostatic hyperplasia in the health professions follow-up study. J Urol 2000;163:490-495.
9. Mitsumori K, Terai A, Oka H, Segawa T, Ogura K, Yoshida O, et al. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH) correlation with adenoma growth. Prostate 1999;41:23-27.
10. Giovannucci E, Platz EA, Stampfer MJ, Chan A, Krithivas K, Kawachi I, et al. The CAG repeat with the androgen receptor gene and benign prostatic hyperplasia. Urology 1999;53:121-125.
11. Carson C, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 2003;61(Suppl 1):2-7.
12. Sciarra F, Toscano V. Role of estrogens in human benign prostatic hyperplasia. Arch Androl 2000;2000:213-220.
13. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 2002;54:935-944.
14. Lagiou P, Mantzoros CS, Tzonou A, Signorello LB, Lipworth L, Trichopoulos D. Serum steroids in relation to benign prostatic hyperplasia. Oncology 1997;54:497-501.
15. Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO, Trichopoulous D. Diet and benign prostatic hyperplasia: A study in Greece. Urology 1999;54:284-290.
16. Lee E, Yoo KY, Kim Y, Shin Y, Lee C. Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur Urol 1998;33:17-21.
17. Hammarsten J, Hogstedt B. Clinical anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999;8:29-36.
18. Teh GC, Sahabudin RM, Lim TC, Chong WL, Woo S, Mohan M, et al. Prevalence of symptomatic BPE among Malaysian men aged 50 and above attending screening during a prostate health awareness campaign. Med J Malaysia 2001;567:186-195.
19. Kittles RA, Young D, Weinrich S, Hudson J, Argyropoulos G, Ukoli F, et al. Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: Implications for prostate cancer risk. Hum Gen 2001;109(3):253-261.
20. Campbell BC, Leslie PW. Reproductive ecology of human males. Yrbk Phys Anthropol 1995;38:1-26.
21. Ellison PT, Bribiescas RG, Bentley GR, Campbell BC, Lipson SF, Panter-Brick C, et al. Population variation in age-related decline in male salivary testosterone. Hum Reprod 2002;17:3251-3253.
22. Fratkin E. Ariaal Pastoralists of Kenya: Surviving Drought and Development in Africa's Arid Lands. Needham Heights: Allyn and Bacon; 1998.
23. Campbell BC, O'Rourke MT, Lipson SF. Salivary testosterone and body composition among Ariaal males. Am J Hum Biol 2003;15:697-708.
24. Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported 'benign prostatic hyperplasia' and their effect on quality of life in a community-based survey of men in the UK. Br Int J Urol 1999;83:410-415.
25. Haidinger G, Madersbacher S, Walderhoer T, Lunglmayr G, Vutuc C. The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables. Eur J Epidemiol 1999;15:717-722.
26. Overland GB, Vatten L, Rhodes T, DeMuro C, Jacobsen G, Vada K, et al. Lower urinary tract symptoms, prostate volume and uroflow in Norwegian community men. Eur Urol 2001;39:36-41.
27. Nacey JN, Morum P, Delahunt B. Analysis of the prevalence of voiding symptoms in Maori, Pacific Island and Caucasian New Zealand men. Urology 1995;46:506-511.
28. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgreve HI, Mebust WK, et al. The American urological association symptom index for benign prostatic hyperplasia. J Urol 1984;148:1549-1557.
29. Ellison PT. Human salivary steroids: Methodological considerations and applications in physical anthropology. Yrbk Phys Anthropol 1988;31:1115-1142.
30. Gray PB. Marriage, parenting and testosterone variation among Kenyan Swahili men. Am J Phys Anthropol 2003;122:279-286.
31. Burnham TC, Flynn-Chapman J, Gray PB, McIntyre MH, Lipson SF, Ellison PT. Men in committed, romantic relationships have lower testosterone (unpublished manuscript).
32. Kambal A. Prostatic obstruction in Sudan. Br J Urol 1977;49:139-141.
33. Dawam D, Rafindadi AH, Kalayi G. Benign prostatic hyperplasia and prostate carcinoma in native Africans. Br Int J Urol 2000;85:1074-1077.
34. Araki H, Watanabe H, Mishina T, Nakao M. High risk group for benign prostatic hypertrophy. Prostate 1983;4:253-264.
35. Lipsky BA. Prostatitis and urinary tract infection in men: What's new: What's true. Am J Med 1999;106:327-334.
36. Nickel JC, Downey J, Young I, Boag S. Asymptomatic inflammation and/or benign prostatic hyperplasia. Br Int J Urol 1999;84:976-981.
37. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. From the cover: Bad bugs and beleagured bladders: Interplay between uropathogenic Escherichia coli and innate host defenses. PNAS (USA) 2000;97:8829-8835.
38. Assumpcao C. Some urinary tract disease in Australian aboriginal inpatients in 1980. Austr NZ J Med 1988;18(1):17-20.